DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
Source | Last Updated |
---|---|
DisGeNET | July 29, 2024 |
Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
---|---|---|---|---|---|
C0600139 | Prostate carcinoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0011847 | Diabetes | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0019159 | Hepatitis A | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0302592 | Cervix carcinoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C1514428 | Primary peritoneal carcinoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0152018 | Esophageal carcinoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0751690 | Malignant Peripheral Nerve Sheath Tumor | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0700095 | Central neuroblastoma | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0019158 | Hepatitis | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0011849 | Diabetes Mellitus | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0025517 | Metabolic Diseases | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0400966 | Non-alcoholic Fatty Liver Disease | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0010068 | Coronary heart disease | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C0546837 | Malignant neoplasm of esophagus | PARP2 | 10038 | poly(ADP-ribose) polymerase 2 | Q9UGN5 |
C3714756 | Intellectual Disability | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0027066 | Myoclonus | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0036439 | Scoliosis, unspecified | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0025362 | Mental Retardation | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0085681 | Hyperphosphatemia (disorder) | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0004903 | Beckwith-Wiedemann Syndrome | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0036857 | Severe intellectual disability | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0020295 | Hydronephrosis | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0006826 | Malignant Neoplasms | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0039446 | Telangiectasis | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
C0494475 | Tonic - clonic seizures | PGAP2 | 27315 | post-GPI attachment to proteins 2 | Q9UHJ9 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024